A novel NF-kappaB binding site controls human granzyme B gene transcription

J Immunol. 2006 Apr 1;176(7):4173-81. doi: 10.4049/jimmunol.176.7.4173.

Abstract

Granzyme B expression is essential for eliciting NK cell cytotoxicity and T cell function. However, its transcriptional regulatory mechanism is not well understood. In this report, we demonstrate in human NK cells and T cells that the NF-kappaB-signaling pathway is involved in such control. Furthermore, a novel downstream human granzyme B gene sequence (GGAGATTCCC) was identified for NF-kappaB binding. EMSA, luciferase, and chromatin immunoprecipitation assays in vitro and in vivo indicated that this NF-kappaB binding site is functional in an NK cell line and its primary counterpart. Our data also demonstrate that this binding site is functional in Jurkat T cells. Taken together, we identified a novel NF-kappaB binding site, which plays a pivotal role in controlling human granzyme B gene transcription.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Binding Sites
  • Cells, Cultured
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics*
  • Granzymes
  • Humans
  • Interleukin-2 / pharmacology
  • Molecular Sequence Data
  • NF-kappa B / classification
  • NF-kappa B / metabolism*
  • Promoter Regions, Genetic / genetics
  • Protein Binding
  • Serine Endopeptidases / genetics*
  • Signal Transduction
  • Transcription, Genetic / genetics*

Substances

  • Interleukin-2
  • NF-kappa B
  • GZMB protein, human
  • Granzymes
  • Serine Endopeptidases